Retrospective outcomes of glucose control in critically ill children

Sarah B Kandil1, Debra Spear, Neal J Thomas

  • 1Department of Pediatrics, Section of Pediatric Critical Care Medicine, Yale University School of Medicine, 333 Cedar St., P.O. Box 208064, New Haven, CT 06520-8064. sarah.kandil@yale.edu.

Insights

Controlling high blood glucose (BG) in critically ill children with insulin did not improve outcomes and was associated with fewer intensive care unit (ICU)-free days. Further randomized trials are needed to clarify glucose control benefits.

Area of Science:

  • Pediatric Critical Care Medicine
  • Endocrinology
  • Metabolic Disorders

Background:

  • Hyperglycemia is a common and concerning issue in critically ill children.
  • Current treatment strategies for hyperglycemia in this population lack consensus.
  • This study investigates the impact of blood glucose control interventions.

Purpose of the Study:

  • To evaluate the effect of insulin therapy for hyperglycemia on outcomes in critically ill children.
  • To compare outcomes between hyperglycemic children receiving insulin and those not receiving interventions.

Main Methods:

  • Retrospective cohort study comparing a treatment group (insulin for BG ≥ 150 mg/dl) with a historical baseline group.
  • Included nondiabetic critically ill children requiring mechanical ventilation and/or vasopressors.
  • Analyzed intensive care unit (ICU)-free days, ventilator-free days, vasopressor-free days, and mortality.

Main Results:

  • The treatment group (n=130) had lower mean BG (140 mg/dl) than the baseline group (n=137, 179 mg/dl).
  • The treatment group experienced 2.5 fewer ICU-free days (p=.023) after adjustment.
  • No significant association found between glucose control and ICU stay duration, ventilator/vasopressor-free days, or mortality.

Conclusions:

  • Blood glucose control in critically ill children may be associated with adverse outcomes.
  • Conflicting evidence from adult studies necessitates caution.
  • Strong recommendation for randomized controlled trials to definitively assess glucose control efficacy in pediatric critical care.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
35
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
34
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K